SCHEMBL8950328

SCHEMBL8950328

CC(C)(C)NS(=O)(=O)c1cc2c(s1)S(=O)(=O)N(CCO)C=C2

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8950595 0.87 CA2 (0.33) CA2
SCHEMBL8950622 0.85
SCHEMBL8950370 0.82 KDM1A (0.32)
SCHEMBL8950316 0.81 CA2 (0.35) CA2
SCHEMBL8950362 0.76 CA2 (0.35) CA2
SCHEMBL8950356 0.76 CA2 (0.35) CA2
SCHEMBL9058369 0.75
SCHEMBL7938911 0.68 CA2 (0.47) CA2
SCHEMBL7941140 0.68
SCHEMBL8950392 0.68 CA2 (0.47) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5538966-A ENZYME INHIBITORS FOR TREATMENT OF GLAUCOMA ALCON LABORATORIES, INC. (US) 1996-07-23 US disclosed